FDA Drug Safety Communications connect consumers and health care professionals to important drug safety information. The webpage contains the most recent Drug Safety Communications from FDA as well as links for Early Communications, Follow-Up Early Communications, Information for Healthcare Professi
Similar Posts
Early Alert: Stent and Electrocautery-Enhanced Delivery System Issue from Boston Scientific
Boston Scientific is removing certain stents and delivery systems due to issues with deployment and expansion.www.usaquickmeds.com – 713312 – 08/01/2025
Misbranded and Unapproved New DrugsModern Warrior Recalls “Modern Warrior Ready” Dietary Supplement Due to Undeclared 1,4-DMAA and Aniracetam, as Well as Tianeptine, Which has Not Been Approved for Supplement Use by the FDA.
[Phoenix, Arizona] – [12/22/25] – Modern Warrior is voluntarily recalling all lots of Modern Warrior Ready, a dietary supplement sold directly to consumers, after regulatory testing identified the presence of undeclared ingredients, including tianeptine, 1,4-DMAA, and aniracetam..Tianeptine can cFDA’s Labeling Resources for Human Prescription Drugs
FDA’s Labeling Resources for Human Prescription DrugsSumitomo Pharma Co., Ltd. 8/7/2025 483
Record Date: 08/7/2025
Entity Name: Sumitomo Pharma Co., Ltd.
FEI Number: 3003028650
Record Type: 483
Country: Japan
Establishment Type: Drug ManufacturerPushclean Technology Plastik Sanayi Ve Ticaret Ltd. Sirketi – 709156 – 06/16/2025
CGMP/Finished Pharmaceuticals/Adulterated